ACTGNetwork

RSS
Our Network Chair Dr. Dan Kuritzkes presented medical grand rounds at Brigham and Women’s Hospital this morning. His talk, “Towards an HIV Cure: Progress and Pitfalls,” focused on the lessons learned from the Berlin Patient, the two Boston patients and the Mississippi baby.
#hiv #aids #cure #research #actg2014 http://ift.tt/1tx2Age

Our Network Chair Dr. Dan Kuritzkes presented medical grand rounds at Brigham and Women’s Hospital this morning. His talk, “Towards an HIV Cure: Progress and Pitfalls,” focused on the lessons learned from the Berlin Patient, the two Boston patients and the Mississippi baby.
#hiv #aids #cure #research #actg2014 http://ift.tt/1tx2Age

Our Network Chair Dr. Dan Kuritzkes presented medical grand rounds at Brigham and Women’s Hospital this morning. His talk, “Towards an HIV Cure: Progress and Pitfalls,” focused on the lessons learned from the Berlin Patient, the two Boston patients and the Mississippi baby.

Our Network Chair Dr. Dan Kuritzkes presented medical grand rounds at Brigham and Women’s Hospital this morning. His talk, “Towards an HIV Cure: Progress and Pitfalls,” focused on the lessons learned from the Berlin Patient, the two Boston patients and the Mississippi baby.

(Source: actgnetwork.org)

A message from our site in Puerto Rico: Hoy Día de Concientización del VIH y SIDA es personas mayores DAMOS LA CARA AL SIDA
#nhaaad #actg2014 #sida #vih #puertorico http://instagram.com/p/tGFEN-KNH2/

A message from our site in Puerto Rico: Hoy Día de Concientización del VIH y SIDA es personas mayores DAMOS LA CARA AL SIDA
#nhaaad #actg2014 #sida #vih #puertorico http://instagram.com/p/tGFEN-KNH2/

A message from our site in Puerto Rico: Hoy Día de Concientización del VIH y SIDA es personas mayores DAMOS LA CARA AL SIDA

Today is National HIV/AIDS and Aging Awareness Day. Our study participant Ed shares why he decided to join our enrolling aging and HIV trial - the HAILO study. He is most concerned with developing heart disease or cancer as he ages, and he wonders if either condition would occur as a direct result of the medications he takes to control his HIV.
#hiv #aids #actg2014 #aging #nhaaad http://ift.tt/1mfCyxb

Today is National HIV/AIDS and Aging Awareness Day. Our study participant Ed shares why he decided to join our enrolling aging and HIV trial - the HAILO study. He is most concerned with developing heart disease or cancer as he ages, and he wonders if either condition would occur as a direct result of the medications he takes to control his HIV.
#hiv #aids #actg2014 #aging #nhaaad http://ift.tt/1mfCyxb

Today is National HIV/AIDS and Aging Awareness Day. Our study participant Ed shares why he decided to join our enrolling aging and HIV trial - the HAILO study. He is most concerned with developing heart disease or cancer as he ages, and he wonders if either condition would occur as a direct result of the medications he takes to control his HIV. Click here to learn more.

Today is National HIV/AIDS and Aging Awareness Day. Our study participant Ed shares why he decided to join our enrolling aging and HIV trial - the HAILO study. He is most concerned with developing heart disease or cancer as he ages, and he wonders if either condition would occur as a direct result of the medications he takes to control his HIV. Click here to learn more.

In this week’s World Wednesday post we look at our four new research sites in Cape Town, South Africa. These sites have a strong track record in tuberculosis trials. This is important work as 25 percent of the world’s TB cases are in Africa.
#actg2014 #aids #hiv #tb #tuberculosis #research #science #southafrica #capetown #worldwednesday http://ift.tt/1teHqTT

In this week’s World Wednesday post we look at our four new research sites in Cape Town, South Africa. These sites have a strong track record in tuberculosis trials. This is important work as 25 percent of the world’s TB cases are in Africa.
#actg2014 #aids #hiv #tb #tuberculosis #research #science #southafrica #capetown #worldwednesday http://ift.tt/1teHqTT

In this week’s World Wednesday post we look at our four new research sites in Cape Town, South Africa. These sites have a strong track record in tuberculosis trials. This is important work as 25 percent of the world’s TB cases are in Africa. Click here to read more about their enrolling studies.

In this week’s World Wednesday post we look at our four new research sites in Cape Town, South Africa. These sites have a strong track record in tuberculosis trials. This is important work as 25 percent of the world’s TB cases are in Africa. Click here to read more about their enrolling studies.

Dr. Eric Daar leads our UCLA research site. He has devoted his career to identifying the most effective forms of antiretroviral therapy. He also thinks it is important to include the community’s input in research studies. #actg2014 #hiv #aids #ucla #research #antiretroviraltherapy http://ift.tt/1qJ8drV

Dr. Eric Daar leads our UCLA research site. He has devoted his career to identifying the most effective forms of antiretroviral therapy. He also thinks it is important to include the community’s input in research studies. #actg2014 #hiv #aids #ucla #research #antiretroviraltherapy http://ift.tt/1qJ8drV

UCLA Researcher Strives to Improve ART | AIDS Clinical Trials Group

Dr. Eric Daar leads our UCLA research site. He has devoted his career to identifying the most effective forms of antiretroviral therapy. Read more about his work and why he thinks it is important to include the community’s input in research.